Adult right hepatic lobe living donor liver transplantation (LDLT) has rapidly gained widespread acceptance as an effective procedure for selected patients with end-stage liver disease. However, there are currently no published data on the effect of this procedure on the quality of life of donors. We report the results of a survey of our living liver transplant donors to determine the effect of right hepatic lobe donation on quality of life. We have performed 30 LDLTs since 1997; 24 of these have a follow-up of 4 months or longer. In August 2000, these patients were sent a questionnaire (including a Medical Outcomes Study 36-Item Short-Form Survey) regarding psychosocial outcomes and symptoms after surgery. Major complications occurred in 4 of 24 patients (16%), and minor complications, in 4 of 24 patients (16%). Complete recovery occurred in 75% of patients at a mean time of 3.4 months. Ninety-six percent of patients returned to the same predonation job after a mean time of 2.4 months, and 66% of patients required a period of light-duty work for a mean of 2.8 months before returning to full-duty work. A change in body image was reported in 42% of patients, and 71% reported mild ongoing symptoms (primarily abdominal discomfort) that they related to the donor surgery for which 29% sought evaluation by a physician. The donor's relationship with the recipient was the same or better in 96% of donors, and the relationship with the donor's significant other was the same or better in 88% of donors. Mean out-of-pocket expenses incurred by donors were $3,660. Sixty-three percent of donors reported experiencing more pain than anticipated. All patients would donate again if necessary, and 96% benefited from the donor experience. In conclusion, (1) all our donors are alive and well after donation; (2) almost all donors were able to return to predonation employment status within a few months; (3) most donors have mild persistent abdominal symptoms, and some donors had a change in body image that they attribute to the donor surgery; and (4) this information should be provided to potential donors so they may better understand the impact of donor surgery. (Liver Transpl 2001;7:485-493.)
Despite extensive preoperative screening, some donors experience severe psychiatric complications, including suicide, after liver donation. Psychiatric assessment and monitoring of liver donors may help to understand and prevent such tragic events.
As a response to our rapidly aging society, professional training programs in health care need to offer rich applied learning experiences with older adults and educate students about ageist attitudes. Health care professionals are likely to work with older adults in a variety of settings, yet ageist attitudes continue to be a barrier to workforce development. This study evaluated the effects of an intergenerational lifelong learning initiative as a way to decrease ageist attitudes in social work students. The research hypothesis was that intergenerational engagement would help reduce ageist attitudes of social work students. Paired samples t tests were conducted with 32 students through pre- and post-surveys of the ROPE (Relating to Old People Evaluation). Results indicated a significant decrease in ageist attitudes overall, in negative ageism, and in students’ self-report of behaviors such as complimenting older adults “despite their age” and avoiding older adults. Qualitative comments indicated significant changes in perception about the aging experience and increased awareness of ageist stereotypes. Overall, this pilot study offers an encouraging model that can be applied through future partnerships to reduce ageism of students in health care–related fields.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.